QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
The abstract ‘Time Since Prior Fracture is Associated with Subsequent Fracture Risk: An Analysis of Real-World Data’ to be presented orally at ASBMR 2019
The abstract ‘Time Since Prior Fracture is Associated with Subsequent Fracture Risk: An Analysis of Real-World Data’, co-authored by Quantify’s Gustaf Ortsäter and Jonas Banefelt, will be presented orally at the American Society of Bone and Mineral Research 2019 annual meeting, to be held in Orlando, Florida, September 20-23.
Quantify kicked off the autumn season in the Stockholm archipelago
Quantify just kicked off the autumn season out in the beautiful Stockholm archipelago, with team building activities such as kayaking, best practice seminars and relaxing in the spa. Having returned to the office with renewed energy, we are eager to start digging into all the new data that has recently been delivered. We have several pan-Nordic research projects underway, […]
Systematic literature review exploring key outcomes in Alzheimer’s disease published in Alzheimer’s & Dementia
The paper “What outcomes are important to patients with mild cognitive impairment or Alzheimer’s disease, their caregivers, and health-care professionals? A systematic review.”, co-authored by Quantify’s Anders Gustavsson has been published in Alzheimer’s & Dementia.
The review identifies a wide range of important outcomes from the perspectives of patients, their caregivers and health-care professionals. They include hallmarks of AD including cognition and function but also other outcomes that […]
Paper on the impact of clinical factors on the risk of fracture in younger and older women has been published
The paper ‘Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic population‘, co-authored by Quantify’s Rosa Lauppe, Gustaf Ortsäter and Oskar Ström has been published in Archives of Osteoporosis.
This study assesses the impact of classical risk factors for fracture in women aged 80+ and 60–79. The results suggest that risk assessment which […]